Broadview Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 9

Professionals
  • Investments
  • 75

  • Portfolio
  • 30

  • Exits
  • 20

Exits

Broadview Ventures General Information

Description

Founded in 2008, Broadview Ventures is a venture capital firm based in Boston, Massachusetts. The firm seeks to invest in companies operating in the small molecules, biologics, generic medicines, cell, gene therapies, implantable, interventional, remote monitoring devices, stand-alone or companion diagnostics, including in vitro, imaging, and digital technologies sectors based in North America, Europe, and Israel. The firm's primary investment goal is to improve human health in the areas of cardiovascular disease and stroke.

Contact Information

Year Founded
2008
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Impact Investing
Primary Office
  • 265 Franklin Street
  • Suite 1902
  • Boston, MA 02110
  • United States
+1 (617) 000-0000

Broadview Ventures Investments & Acquisitions (75)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cardiosense 08-Dec-2022 Early Stage VC 000.00 Monitoring Equipment Startup 000000 00000000
0000 0000000 23-Nov-2022 00000 00000 0000 Surgical Devices Pre-Clinical Trials
0000000000 (000000 31-Aug-2022 00000 00000 000.00 Therapeutic Devices Startup
000 0000000 29-Apr-2022 00000 00000 000.00 Therapeutic Devices Generating Revenue
0000 000000000000 09-Feb-2022 0000 00000 000.00 Drug Discovery Generating Revenue 00000000 00000000
000000000 04-Feb-2022 00000 00000 00.00 Surgical Devices Generating Revenue
000000 0000000 000 24-Jan-2022 0000 00000 Therapeutic Devices Clinical Trials - Phase 1 00000000000 00000000
000000000 30-Dec-2021 00000 00000 0000 Surgical Devices Generating Revenue
Kantum Pharma 12-Jul-2021 Seed Round 00.000 Biotechnology Generating Revenue 000000 0000000 00.
Comanche Biopharma 28-Jun-2021 Early Stage VC 0000 Biotechnology Generating Revenue
You’re viewing 10 of 75 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Broadview Ventures Exits (20)

Company Name Exit Date Exit Type Exit Size
Cardialen 14-Dec-2022 Merger/Acquisition
0000000000 01-May-2022 000 00 00000000
000000000 02-Sep-2021 0000000 000000 000.00
0000000000 0000000 08-May-2020 000 00 00000000
0000 000000000000 01-May-2020 000 0000
000000 000000000 01-May-2020 000 00 00000000
000000000 0000000 01-Jan-2020 0000000000: 000000
000000000 00000000 27-Dec-2017 000 00 00000000
Apama Medical 10-Oct-2017 Merger/Acquisition 00000
Remedy Pharmaceuticals 01-May-2017 Secondary Transaction - Private
You’re viewing 10 of 20 exits. Get the full list »

Broadview Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Broadview Ventures Team (30)

Name Title Deals Funds Boards Office
Christopher Colecchi Managing Director 0 0 Boston, MA
Benjamin Kreitman Principal 0 0 Boston, MA
Hewmun Lau Principal 0 Boston, MA
Maria Berkman MD Director & Head of the MedTech Practice 00 0 Boston, MA
Christopher De Souza Ph.D Director 0 0 Boston, MA
You’re viewing 5 of 30 team members. Get the full list »

Broadview Ventures Co-Investors (79)

Name With Exits Lead Partner Series Industry
Hatteras Venture Partners 3 0 Series chart Industry bar
Long View Equity Partners 0 0 0 Series chart Industry bar
Catalyst Health Ventures 0 0 Series chart Industry bar
Epidarex Capital 0 Series chart Industry bar
Vensana Capital 0 0 Series chart Industry bar
You’re viewing 5 of 79 co-investors. Get the full list »